Neurocrine Biosciences

NBIX

NASDAQHealth Care

Income Statement

Total Revenue$2.36B

Gross Profit$2.32B

Operating Income$570.5M

EBITDA$523.5M

EBIT$486M

Pre-tax Income$937.5M

Net Income$341.3M

Cash Equivalent$279.53M

Total Debt$368.65M

Book Value$2.55B

Book Value Per Share25.36

Return on Equity (ROE)+13.18%

Return on Assets (ROA)+9.18%

Return on Invested Capital (ROI)+13.18%

Net Profit Margin+14.49%

Current Ratio3.40

Quick Ratio3.28

Long-Term Debt / Equity0.00